AR241785A1 - Procedimiento para obtener derivados de 3-(alcantio) -7-oxo-1-azabiciclo (3,2,0)-help-2-en-2-carboxilato y sus sales. - Google Patents

Procedimiento para obtener derivados de 3-(alcantio) -7-oxo-1-azabiciclo (3,2,0)-help-2-en-2-carboxilato y sus sales.

Info

Publication number
AR241785A1
AR241785A1 AR83294329A AR29432983A AR241785A1 AR 241785 A1 AR241785 A1 AR 241785A1 AR 83294329 A AR83294329 A AR 83294329A AR 29432983 A AR29432983 A AR 29432983A AR 241785 A1 AR241785 A1 AR 241785A1
Authority
AR
Argentina
Prior art keywords
formula
compound
pirid
carboxi
protector
Prior art date
Application number
AR83294329A
Other languages
English (en)
Spanish (es)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of AR241785A1 publication Critical patent/AR241785A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/061,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65611Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
AR83294329A 1982-09-28 1983-09-27 Procedimiento para obtener derivados de 3-(alcantio) -7-oxo-1-azabiciclo (3,2,0)-help-2-en-2-carboxilato y sus sales. AR241785A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42575582A 1982-09-28 1982-09-28
US53001183A 1983-09-09 1983-09-09

Publications (1)

Publication Number Publication Date
AR241785A1 true AR241785A1 (es) 1992-12-30

Family

ID=27026797

Family Applications (1)

Application Number Title Priority Date Filing Date
AR83294329A AR241785A1 (es) 1982-09-28 1983-09-27 Procedimiento para obtener derivados de 3-(alcantio) -7-oxo-1-azabiciclo (3,2,0)-help-2-en-2-carboxilato y sus sales.

Country Status (29)

Country Link
KR (1) KR890002228B1 (de)
AR (1) AR241785A1 (de)
AT (1) AT382621B (de)
AU (1) AU575541B2 (de)
CA (1) CA1269978A (de)
CH (1) CH656130A5 (de)
CS (1) CS247168B2 (de)
DD (1) DD212255A5 (de)
DE (1) DE3334937A1 (de)
DK (1) DK442383A (de)
ES (1) ES8503354A1 (de)
FI (1) FI78094C (de)
FR (1) FR2533568B1 (de)
GB (1) GB2128187B (de)
GR (1) GR78696B (de)
HU (1) HU191066B (de)
IE (1) IE55947B1 (de)
IL (1) IL69824A (de)
IT (1) IT1163944B (de)
LU (1) LU85021A1 (de)
NL (1) NL8303310A (de)
NO (1) NO163284C (de)
NZ (1) NZ205626A (de)
OA (1) OA07548A (de)
PT (1) PT77404B (de)
SE (1) SE461734B (de)
SU (1) SU1493108A3 (de)
YU (1) YU43196B (de)
ZW (1) ZW20783A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683296A (en) * 1983-03-07 1987-07-28 Bristol-Myers Company Carbapenem intermediates
CA1273012A (en) * 1984-07-02 1990-08-21 Burton G. Christensen 1-methylcarbapenems having an externally alkylated mono- of bicyclic 2-quarternary heteroarylalkylthio substituent
CA1273011A (en) * 1984-07-02 1990-08-21 Susan M. Schmitt Carbapenems having an externally alkylated mono- or bicyclic 2-quaternary heteroarylalkylthio substituent
US4729993A (en) * 1984-12-13 1988-03-08 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having an externally alkylated mono- or bicyclic 2-quaternary heteroarylalkyl substituent
US4725594A (en) * 1984-12-13 1988-02-16 Merck & Co., Inc. Carbapenems having an internally or externally alkylated mono- or bicyclic 2-quaternary heteroarylalxyl heteromethyl substituent
US4680292A (en) * 1984-12-13 1987-07-14 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having a 2-heteroaryliumaliphatic substituent
US4665169A (en) * 1985-09-11 1987-05-12 Bristol-Myers Company Carbapenem antibiotics
US4880922A (en) * 1985-11-22 1989-11-14 Bristol-Myers Company Carbapenems with quaternized heterothioalkylthio substitution at position 2
NZ219892A (en) * 1986-04-15 1991-02-26 Merck & Co Inc N-amino quaternised heteroarylium carbapenem derivatives and pharmaceutical compositions thereof
DK168047B1 (da) * 1987-12-07 1994-01-24 Lederle Japan Ltd (1r,5s,6s)-2-substitueret thio-6-oe(r)-1-hydroxyethylaa-1-methyl-carbapenem-3-carboxylsyrederivater, fremgangsmaade til remstilling deraf, midler og praeparater indeholdende den krystallinske forbindelse samt dens anvendelse.
EP0876370A1 (de) 1996-01-12 1998-11-11 Takeda Chemical Industries, Ltd. Carbapenemverbindungen, ihre herstellung und verwendung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0017992A1 (de) * 1979-04-19 1980-10-29 Merck & Co. Inc. 2-Substituierte-6-substituierte-1-Carbadethiapen-2-em-3-carbonsäuren, Verfahren zu ihrer Herstellung, sie enthaltende antibiotische pharmazeutische Zusammensetzungen und Verfahren zur Herstellung von Zwischenprodukten
IE52147B1 (en) * 1980-03-27 1987-07-08 Merck & Co Inc 4-(3-carboxy-2-oxopropyl)-azetidin-2-ones and process for their preparation
EP0038869A1 (de) * 1980-04-30 1981-11-04 Merck & Co. Inc. Verfahren zur Herstellung von 1-Carbapenemen und Zwischenprodukte für ihre Herstellung
PT73791B (en) * 1980-10-17 1983-10-14 Merck & Co Inc Process for preparing 2-carbamimidoyl-6-substituted-1- -carbadethiapen-2-em-3-carboxylic acids
EP0050927B1 (de) * 1980-10-25 1985-03-27 Beecham Group Plc Herstellung von Beta-Lactam-Antibiotika
US4552873A (en) * 1981-08-19 1985-11-12 Sankyo Company Limited Carbapenem compounds, and compositions containing them
EP0074599A1 (de) * 1981-09-09 1983-03-23 Takeda Chemical Industries, Ltd. 5,6-Cis-Carbapenem-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
CS247168B2 (en) 1986-12-18
IE55947B1 (en) 1991-02-27
KR840006249A (ko) 1984-11-22
FI78094B (fi) 1989-02-28
NO163284B (no) 1990-01-22
OA07548A (fr) 1985-03-31
NO833479L (no) 1984-03-29
GB2128187B (en) 1986-06-18
FR2533568B1 (fr) 1990-01-26
DK442383D0 (da) 1983-09-27
DE3334937A1 (de) 1984-04-05
IL69824A0 (en) 1983-12-30
DD212255A5 (de) 1984-08-08
CH656130A5 (de) 1986-06-13
YU43196B (en) 1989-04-30
PT77404B (en) 1986-06-26
NL8303310A (nl) 1984-04-16
ES525983A0 (es) 1985-02-16
ES8503354A1 (es) 1985-02-16
SU1493108A3 (ru) 1989-07-07
IL69824A (en) 1991-04-15
HU191066B (en) 1987-01-28
CA1269978A (en) 1990-06-05
IT8323022A0 (it) 1983-09-27
DK442383A (da) 1984-03-29
SE8305217L (sv) 1984-03-29
SE461734B (sv) 1990-03-19
LU85021A1 (fr) 1984-04-24
FR2533568A1 (fr) 1984-03-30
AT382621B (de) 1987-03-25
FI78094C (fi) 1989-06-12
ATA344983A (de) 1986-08-15
GB2128187A (en) 1984-04-26
FI833417A0 (fi) 1983-09-23
NZ205626A (en) 1986-12-05
GR78696B (de) 1984-09-27
IT1163944B (it) 1987-04-08
GB8325744D0 (en) 1983-10-26
AU1934283A (en) 1984-04-05
PT77404A (en) 1983-10-01
IE832266L (en) 1984-03-28
NO163284C (no) 1990-05-02
DE3334937C2 (de) 1991-05-02
ZW20783A1 (en) 1984-11-28
SE8305217D0 (sv) 1983-09-27
KR890002228B1 (ko) 1989-06-24
FI833417A (fi) 1984-03-29
YU190683A (en) 1985-10-31
AU575541B2 (en) 1988-08-04

Similar Documents

Publication Publication Date Title
MX167182B (es) Compuestos de imidazol y composicion biocida que los comprende, para controlar organismos dañinos
PT73982A (en) Process for preparing 3-aryloxy-3-phenylpropylamines
FR2446289A1 (fr) Compose de 2-penem, procede de preparation et composition pharmaceutique obtenue
AR241785A1 (es) Procedimiento para obtener derivados de 3-(alcantio) -7-oxo-1-azabiciclo (3,2,0)-help-2-en-2-carboxilato y sus sales.
GB1106040A (en) Novel benzdiaz[1,4]epine derivatives and a process for the manufacture thereof
DE3363593D1 (en) 2-nitro-ethene diamines, process for their preparation and their use as medicines
JPS5750989A (en) Imidazole compound
BR8300419A (pt) Emprego de hidroxialquilfenonas e processo para a fotopolimerizacao de compostos etilenicamente insaturados
DE3061125D1 (en) 1-(naphthyl-n-propyl)imidazole derivatives, compositions containing them, methods of making them and their use for pharmaceuticals
IL86723A (en) Guanidine-related compounds comprising a tetraphenyl- borate ion and process for their preparation
GB1070228A (en) Improvements in or relating to the preparation of organoantimony compounds
DE3374005D1 (en) 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle
ATE20588T1 (de) Heterozyklische verbindungen geeignet als pestizide und verfahren zu ihrer herstellung.
ES8205219A1 (es) Un metodo para producir un compuesto de hidrouracilo
ES8404150A1 (es) Procedimiento para la preparacion de n-pteridinilureas.
GB1421600A (en) Process for the production of aromatic diamines
IL86722A0 (en) Guanidine-related compounds comprising a tetraphenylborate ion,their preparation and their use
UA6020A1 (uk) Спосіб одержання n-метіл-n-/2-(2-діметіламінометіл тіазол-4-ілметілтіо)-етіл/-2-нітро-1,1-етендіаміна
ES8504736A1 (es) Un procedimiento para la preparacion de compuestos de imidazolilpropanol opticamente activos
DE3060305D1 (en) Cyclophosphathiazenes, process for their preparation and compositions containing them
ES8400741A1 (es) Procedimiento para la preparacion de un derivado de dibenzoxepinona.
PT78364A (en) Process for preparing iminosulphonamides from pharmaceutic preparation wich contain these compounds and its therapeutical utilization
IL71987A (en) N-(beta-fluoroethyl)nortropine,its preparation and use in preparation of the corresponding 3-alpha-benzilate
GB2005250A (en) (1-Alkylpyrrolyl-2)thio- acetamides
CH608797A5 (en) Process for the preparation of heterocyclic compounds